In Bujumbura, the Government of Burundi has officially launched the human papillomavirus (HPV) vaccine with support from global partners including Gavi, the Vaccine Alliance, UNICEF, and the World Health Organization. This marks a major step forward in preventing cervical cancer, one of the leading causes of death among women in the country.
Cervical cancer remains a significant public health challenge in Burundi, with high incidence and mortality rates in recent years. The disease, caused by persistent infection with HPV, disproportionately affects low- and middle-income countries where access to vaccination and screening is limited. With a large population of women at risk, the introduction of the HPV vaccine is seen as a critical preventive measure.
The rollout builds on the success of earlier pilot programmes conducted between 2016 and 2018, which demonstrated strong community acceptance and high vaccination coverage among young girls. These results provided a solid foundation for expanding the programme nationwide.
To ensure effective implementation, the government is coordinating a broad national effort involving health professionals, community leaders, media, and development partners. Emphasis is being placed on raising awareness, addressing misinformation, and building public trust in the vaccine through a comprehensive communication strategy.
The vaccination programme is being integrated into the national immunization system, targeting girls aged 9 to 14 across all health districts. A combined approach—including school-based vaccination and community outreach—aims to reach both enrolled and out-of-school girls, with a target of at least 80 percent coverage.
This initiative is part of wider efforts to strengthen Burundi’s health system and expand preventive care. It aligns with global goals to eliminate cervical cancer as a public health problem and reflects growing momentum across Africa, where increasing numbers of countries are introducing HPV vaccination programmes.
Overall, the launch represents a significant investment in the health and future of girls and women in Burundi, with the potential to reduce disease burden, save lives, and contribute to long-term public health improvements.
